90 related articles for article (PubMed ID: 17130840)
1. DNA binding and selective gene induction by different forms of the p53 protein.
Mayelzadeh F; Martinez JD
Oncogene; 2007 May; 26(21):2955-63. PubMed ID: 17130840
[TBL] [Abstract][Full Text] [Related]
2. P53 regulation and function in normal cells and tumors.
Liu Y; Kulesz-Martin M
Medicina (B Aires); 2000; 60 Suppl 2():9-11. PubMed ID: 11188940
[TBL] [Abstract][Full Text] [Related]
3. Reconstitution of wild-type p53 expression triggers apoptosis in a p53-negative v-myc retrovirus-induced T-cell lymphoma line.
Wang Y; Ramqvist T; Szekely L; Axelson H; Klein G; Wiman KG
Cell Growth Differ; 1993 Jun; 4(6):467-73. PubMed ID: 8373731
[TBL] [Abstract][Full Text] [Related]
4. Stable expression of temperature-sensitive p53: a suitable model to study wild-type p53 function in pancreatic carcinoma cells.
Nuevemann D; Christgen M; Ungefroren H; Kalthoff H
Oncol Rep; 2006 Sep; 16(3):575-9. PubMed ID: 16865258
[TBL] [Abstract][Full Text] [Related]
5. Mutant p53 exerts a dominant negative effect by preventing wild-type p53 from binding to the promoter of its target genes.
Willis A; Jung EJ; Wakefield T; Chen X
Oncogene; 2004 Mar; 23(13):2330-8. PubMed ID: 14743206
[TBL] [Abstract][Full Text] [Related]
6. [p53].
Takahashi R
Gan To Kagaku Ryoho; 1997 Sep; 24(11):1381-5. PubMed ID: 9309129
[TBL] [Abstract][Full Text] [Related]
7. p53 and Delta Np63 alpha differentially bind and regulate target genes involved in cell cycle arrest, DNA repair and apoptosis.
Schavolt KL; Pietenpol JA
Oncogene; 2007 Sep; 26(42):6125-32. PubMed ID: 17404570
[TBL] [Abstract][Full Text] [Related]
8. The do's and don'ts of p53 isoforms.
Jänicke RU; Graupner V; Budach W; Essmann F
Biol Chem; 2009 Oct; 390(10):951-63. PubMed ID: 19453282
[TBL] [Abstract][Full Text] [Related]
9. Ribosomal protein S27-like, a p53-inducible modulator of cell fate in response to genotoxic stress.
Li J; Tan J; Zhuang L; Banerjee B; Yang X; Chau JF; Lee PL; Hande MP; Li B; Yu Q
Cancer Res; 2007 Dec; 67(23):11317-26. PubMed ID: 18056458
[TBL] [Abstract][Full Text] [Related]
10. Conformational phenotype of p53 is linked to nuclear translocation.
Gaitonde SV; Riley JR; Qiao D; Martinez JD
Oncogene; 2000 Aug; 19(35):4042-9. PubMed ID: 10962561
[TBL] [Abstract][Full Text] [Related]
11. Characterization of rare p53 mutants from carcinogen-treated albumin-simian virus 40 T-antigen transgenic rats.
Haas MJ; Pitot HC
Mol Carcinog; 1998 Feb; 21(2):128-34. PubMed ID: 9496913
[TBL] [Abstract][Full Text] [Related]
12. Modulation of the cyclin-dependent kinase inhibitor p21(WAF1/Cip1) gene by Zac1 through the antagonistic regulators p53 and histone deacetylase 1 in HeLa Cells.
Liu PY; Chan JY; Lin HC; Wang SL; Liu ST; Ho CL; Chang LC; Huang SM
Mol Cancer Res; 2008 Jul; 6(7):1204-14. PubMed ID: 18644983
[TBL] [Abstract][Full Text] [Related]
13. Living with p53, dying of p53.
Aylon Y; Oren M
Cell; 2007 Aug; 130(4):597-600. PubMed ID: 17719538
[TBL] [Abstract][Full Text] [Related]
14. Restoring wild-type conformation and DNA-binding activity of mutant p53 is insufficient for restoration of transcriptional activity.
Brazda V; Muller P; Brozkova K; Vojtesek B
Biochem Biophys Res Commun; 2006 Dec; 351(2):499-506. PubMed ID: 17070499
[TBL] [Abstract][Full Text] [Related]
15. Induction of apoptosis by vinblastine via c-Jun autoamplification and p53-independent down-regulation of p21WAF1/CIP1.
Kolomeichuk SN; Bene A; Upreti M; Dennis RA; Lyle CS; Rajasekaran M; Chambers TC
Mol Pharmacol; 2008 Jan; 73(1):128-36. PubMed ID: 18094076
[TBL] [Abstract][Full Text] [Related]
16. Restoration of wild-type p53 function in human tumors: strategies for efficient cancer therapy.
Wiman KG
Adv Cancer Res; 2007; 97():321-38. PubMed ID: 17419952
[TBL] [Abstract][Full Text] [Related]
17. [Relevance of p53 protein and its mutations for novel strategies in cancer therapy].
Müller P; Nenutil R; Vojtĕsek B
Cas Lek Cesk; 2004; 143(5):313-7. PubMed ID: 15305766
[TBL] [Abstract][Full Text] [Related]
18. DNA damage signalling recruits RREB-1 to the p53 tumour suppressor promoter.
Liu H; Hew HC; Lu ZG; Yamaguchi T; Miki Y; Yoshida K
Biochem J; 2009 Aug; 422(3):543-51. PubMed ID: 19558368
[TBL] [Abstract][Full Text] [Related]
19. Hypersensitivity to chromium-induced DNA damage correlates with constitutive deregulation of upstream p53 kinases in p21-/- HCT116 colon cancer cells.
Hill R; Leidal AM; Madureira PA; Gillis LD; Cochrane HK; Waisman DM; Chiu A; Lee PW
DNA Repair (Amst); 2008 Feb; 7(2):239-52. PubMed ID: 18024214
[TBL] [Abstract][Full Text] [Related]
20. p53-mediated regulation of cell cycle progression: pronounced impact of cellular microenvironment.
Schmid G; Kramer MP; Wesierska-Gadek J
J Cell Physiol; 2009 May; 219(2):459-69. PubMed ID: 19170070
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]